Effectiveness of vitamin K in anticoagulation reversal for hip fracture surgery--a prospective observational study.

Abstract:

INTRODUCTION:Vitamin K antagonists are often used for anticoagulant treatment in hip fracture patients. The optimal handling with such anticoagulants is unclear. We aimed to determine when anticoagulation reversal occurred after vitamin K administration and how often prothrombin complex concentrates (PCCs) were administered. We compared patients' treatments and outcomes with those of a control group not receiving treatment for anticoagulation. PATIENTS AND METHODS:A total of 402 geriatric hip fracture patients were included in this observational study. We collected data on treatment for anticoagulation, time to surgery, and reasons for delay of surgery. In patients taking vitamin K antagonists, we measured the INR (international normalized ratio) on admission and prior to surgery, along with the frequency of PCC administration. Finally, we compared in-hospital mortality and complications between patient groups. RESULTS:A total of 62 (15%) patients received phenprocoumon prior to their fractures. Surgery was delayed in these patients compared to controls (27h; 95%CI 23-31 vs. 16h; 95%CI 19-19; p=0.001), but surgery delay >48h (n=5; 8%) was not due to a failure of INR reversal. The main reason for these delays was a lack of capacity for surgery. The average INR on admission was 2.1 (±0.7; range 1.0-3.5) in patients taking phenprocoumon, which decreased to 1.3 (±0.3; range 1.0-1.6) until surgery. PCCs were administered to 19% of patients. We found no differences in the in-hospital mortality (6.2% vs. 8.1%, p=0.575) or complication rates (12.9% vs. 9.4%, p=0.364). CONCLUSION:The use of vitamin K seemed to be sufficient for anticoagulation reversal in geriatric hip fracture patients, and it generally led to timely surgery; despite this success, PCCs were sometimes administered for logistical reasons.

journal_name

Thromb Res

journal_title

Thrombosis research

authors

Buecking B,Eschbach D,Bliemel C,Oberkircher L,Struewer J,Ruchholtz S,Sachs UJ

doi

10.1016/j.thromres.2013.10.031

subject

Has Abstract

pub_date

2014-01-01 00:00:00

pages

42-7

issue

1

eissn

0049-3848

issn

1879-2472

pii

S0049-3848(13)00505-7

journal_volume

133

pub_type

杂志文章
  • Genetic prothrombotic risk factors in women with unexplained pregnancy loss.

    abstract:INTRODUCTION:Inherited thrombophilia has been associated with unexplained recurrent pregnancy loss (RPL) and stillbirth. This thrombotic tendency can manifest as thrombotic lesions in the placenta, and may lead to abortion and stillbirth. The aim of our case-control study was to investigate the prevalence of FVL and FI...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2005.06.005

    authors: Sottilotta G,Oriana V,Latella C,Luise F,Piromalli A,Ramirez F,Mammì C,Santoro R,Iannaccaro P,Muleo G,Lombardo VT

    更新日期:2006-01-01 00:00:00

  • CCL5 deficiency reduces neointima formation following arterial injury and thrombosis in apolipoprotein E-deficient mice.

    abstract::Activated platelets secrete different chemokines, among others CCL5, thereby triggering inflammatory cell recruitment into the vessel wall. Here, we investigated how CCL5 deficiency influences vascular remodeling processes. Experiments were performed in apolipoprotein E and CCL5 double deficient (ApoE(-/-)×CCL5(-/-)) ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2016.06.013

    authors: Czepluch FS,Meier J,Binder C,Hasenfuss G,Schäfer K

    更新日期:2016-08-01 00:00:00

  • Oral administration of factor VIII concentrate preparation in von Willebrand's disease.

    abstract::We investigated on how to effectively administer orally factor VIII preparation to two patients with von Willebrand's disease as volunteers, and the following results were obtained: Bleeding time and aPTT were shortened, but no change of PT was observed. Factor VIII:C increased slightly, but no significant increase wa...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(85)90211-7

    authors: Sakuragawa N,Niiya K,Kondo S

    更新日期:1985-06-15 00:00:00

  • Acute hypoxemia does not increase blood fibrinolytic activity in man.

    abstract::The influence of acute hypoxemia on blood fibrinolytic activity was investigated in 12 healthy males. Physiologically significant hypoxemia was produced by inspiration of 13% oxygen for 30 min. Six healthy males were exposed to hypoxemia at rest and 6 males to hypoxemia during exhaustive physical exercise on an ergocy...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(87)90222-2

    authors: Stegnar M,Peternel P,Chen JP

    更新日期:1987-02-15 00:00:00

  • Plasminogen and tissue plasminogen activator interact with antithrombin III.

    abstract::Human antithrombin III was demonstrated to bind plasminogen specifically in a time and concentration-dependent manner. The above binding was also confirmed using ligand western blot assays. The interaction of plasminogen was significantly (>90%) inhibited by lysine, indicating the involvement of kringles in binding an...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(00)00268-1

    authors: Dudani AK

    更新日期:2000-09-15 00:00:00

  • Possible contribution of solid surface for inactivation of thrombin.

    abstract::Dextran sulfate and polybrene were immobilized on polypropylene tubes with plastic adhesive. Serum albumin was also immobilized on the tube by heat-denaturation. In the those tubes thrombin was protected from inactivation in the presence of 0.1 M NaCl remarkably. Cholesterol coated on the tube also protected the enzym...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(88)90277-0

    authors: Oshima G

    更新日期:1988-07-01 00:00:00

  • Quantitative SEM-analysis of adhesive and thrombogenic properties of vascular prostheses.

    abstract::The perfusion technique to measure the relative adhesive and thrombogenic indices of vascular prostheses by a quantitative scanning electron microscopy has been described. To normalize the experiments with different samples of plasma we compared the adhesive and thrombogenic properties of the analyzed prostheses with ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(83)90038-5

    authors: Dolgov VV,Zaikina OE,Repin VS,Smirnov VN,Bujanovsky VL,Kazanchyan PO,Pokrovsky VA

    更新日期:1983-02-01 00:00:00

  • Noninvasive transcutaneous ultrasound augments thrombolysis in the left circumflex coronary artery--an in vivo canine study.

    abstract:BACKGROUND:Ultrasound has the potential to augment chemical thrombolysis. METHODS AND RESULTS:Thrombotic occlusions in the left circumflex artery (LCx) were induced in 27 dogs. Sixty minutes later, tissue-type plasminogen activator (t-PA) was given intravenously over 90 min. Thrombotic occlusions (n = 20) were treated...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(03)00335-9

    authors: Jeon DS,Luo H,Fishbein MC,Miyamoto T,Horzewski M,Iwami T,Mirocha JM,Ikeno F,Honda Y,Siegel RJ

    更新日期:2003-05-01 00:00:00

  • The inhibition of thromboplastin by apolipoprotein-B and the effect of various associated lipids.

    abstract::Human apolipoprotein B was purified by barium sulphate adsorption, subsequent delipidation and gel filtration. The protein was then reconstituted in soya bean lecithin and its inhibitory effect towards thromboplastin was assayed by incubation with rabbit brain thromboplastin. The use of an antibody against human apoli...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(92)90033-7

    authors: Ettelaie C,Howell RM

    更新日期:1992-10-15 00:00:00

  • The use of aspirin for primary and secondary prevention in venous thromboembolism and other cardiovascular disorders.

    abstract::Cardiovascular disease (CVD) includes a number of conditions such as myocardial infarction, coronary heart disease, stroke, and venous thromboembolism. CVD is a leading health problem worldwide and a major cause of mortality, morbidity, and disability; it is also associated with high healthcare costs. The incidence of...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/j.thromres.2014.11.036

    authors: Cohen AT,Imfeld S,Markham J,Granziera S

    更新日期:2015-02-01 00:00:00

  • Heparin dosing for venous thromboembolism prophylaxis in obese hospitalized patients: An observational study.

    abstract:OBJECTIVE:To compare rates of VTE occurrence in obese versus non-obese hospitalized patients who received UFH 5000 units subcutaneously q8 h. MATERIALS AND METHODS:This was a retrospective cohort study conducted in an academic medical center in the United States. Consecutive adult patients who were hospitalized during...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2018.07.027

    authors: Patanwala AE,Seaman SM,Kopp BJ,Erstad BL

    更新日期:2018-09-01 00:00:00

  • Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease.

    abstract:INTRODUCTION:Atherosclerosis, the underlying disorder of coronary artery disease (CAD), is an inflammatory process involving multiple molecular pathways. Chemokine-mediated mechanisms are potent regulators of atherosclerosis. Genetic variations that alter such signaling pathways could affect susceptibility to CAD. We i...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2005.12.016

    authors: Apostolakis S,Baritaki S,Kochiadakis GE,Igoumenidis NE,Panutsopulos D,Spandidos DA

    更新日期:2007-01-01 00:00:00

  • Homozygous protein C deficiency with delayed onset of symptoms at 7 to 10 months.

    abstract::We report an inbred family with two cases of homozygous protein C deficiency and review 11 other such cases. Both patients presented in the second half of their first year of life with recurrent rapidly disappearing ecchymotic skin lesions, disseminated intravascular coagulation, and venous thrombosis. Successful trea...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/0049-3848(89)90202-8

    authors: Tuddenham EG,Takase T,Thomas AE,Awidi AS,Madanat FF,Abu Hajir MM,Kernoff PB,Hoffbrand AV

    更新日期:1989-03-01 00:00:00

  • The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: results from the estrogen in women with atherosclerosis study.

    abstract::Data on the effect of hormone replacement therapy on hemostasis are inconsistent, and there are few data in women with coronary artery disease. In a single-center, open, randomized study, 118 postmenopausal women with angiographically verified coronary artery disease were randomized to hormone replacement therapy, giv...

    journal_title:Thrombosis research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0049-3848(99)00233-9

    authors: Hoibraaten E,Os I,Seljeflot I,Andersen TO,Hofstad A,Sandset PM

    更新日期:2000-04-01 00:00:00

  • The antithrombotic effect of aspirin and dipyridamole in relation to prostaglandin synthesis.

    abstract::The antithrombotic effect of aspirin (ASA) and dipyridamole (DIP) was evaluated in rabbits in which platelet thromboxane A2 (TXA2) and arterial prostacyclin (PGI2) were measured. An intracarotid cannula thrombosis model previously shown to be sensitive to antiplatelet agents was used. Prostaglandins were determined by...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(83)90224-4

    authors: Louie S,Gurewich V

    更新日期:1983-05-15 00:00:00

  • Nonradical excited oxygen species induce selective thrombolysis in vivo.

    abstract::All the thrombolytic agents currently in clinical use act as plasminogen activators. In this study evidence is presented that also oxidants of the phagocyte type are of fibrinolytic efficiency in vivo. Activated phagocytes participate in physiologic fibrinolysis. The cells generate plasminogen activators and reactive ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(91)90189-4

    authors: Stief TW

    更新日期:1991-05-01 00:00:00

  • Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteers.

    abstract::The pharmacokinetics of a low molecular weight heparin (LMWH) with a mean mw of 4000-6000 D (KABI 2165, Fragmin) was studied in 6 healthy volunteers after intravenous (iv) and subcutaneous (sc) administration of 120 U (anti FXa)/kg. The half-life in plasma of the anti FXa activity after iv injection was 119 +/- 17 min...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(86)90340-3

    authors: Bratt G,Törnebohm E,Widlund L,Lockner D

    更新日期:1986-06-01 00:00:00

  • Safety of continuing warfarin therapy during cataract surgery: a systematic review and meta-analysis.

    abstract:BACKGROUND:In patients who are receiving warfarin therapy and require cataract surgery, it may be possible to continue warfarin in the perioperative period but the safety of this management strategy has not been systematically evaluated. METHODS:We performed a systematic review of the literature to assess the safety (...

    journal_title:Thrombosis research

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.thromres.2009.01.007

    authors: Jamula E,Anderson J,Douketis JD

    更新日期:2009-07-01 00:00:00

  • A review of global coagulation assays - Is there a role in thrombosis risk prediction?

    abstract::Normal haemostasis requires maintenance of a careful equilibrium between the necessity to clot when bleeding and the retention of fluid phase at all other times. Disruption of this equilibrium can result in catastrophic outcomes, e.g. acute myocardial infarction and pulmonary embolism. However, despite the significant...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/j.thromres.2019.04.033

    authors: Lim HY,O'Malley C,Donnan G,Nandurkar H,Ho P

    更新日期:2019-07-01 00:00:00

  • Growth and function of the normal human placenta.

    abstract::The placenta is the highly specialised organ of pregnancy that supports the normal growth and development of the fetus. Growth and function of the placenta are precisely regulated and coordinated to ensure the exchange of nutrients and waste products between the maternal and fetal circulatory systems operates at maxim...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/j.thromres.2004.06.038

    authors: Gude NM,Roberts CT,Kalionis B,King RG

    更新日期:2004-01-01 00:00:00

  • Increased fibrinolytic activity after surgery induced by low dose heparin.

    abstract::Forty women undergoing surgery under general anaesthesia for hyperplasia mammae were randomized to treatment with low dose heparin (5000 IU twice daily) or not. Preoperatively, and repeated on the 3. postoperative day, assays of euglobulin clot lysis time (ELT) after venous stasis, tissue plasminogen activator (t-PA) ...

    journal_title:Thrombosis research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0049-3848(87)90318-5

    authors: Arnesen H,Engebretsen LF,Ugland OM,Seljeflot I,Kierulf P

    更新日期:1987-03-01 00:00:00

  • Effects of dietary linoleic acid on rat platelet ADP-induced aggregation and binding of 125I-fibrinogen.

    abstract::Platelets from rats fed a diet high in linoleic acid (6%) bound increased amounts of fibrinogen on stimulation with ADP, compared to those from rats fed diets with low (2%) or no linoleic acid. However, this increased fibrinogen binding was associated with a decrease in platelet aggregation induced by ADP. Changes in ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(84)90107-5

    authors: McGregor L,Toor B,McGregor JL,Renaud S,Clemetson KJ

    更新日期:1984-04-01 00:00:00

  • Thromboembolism and anticoagulant management in hemodialysis patients: a practical guide to clinical management.

    abstract::The need for anticoagulation in dialysis patients is common and the incidence of venous thromboembolism (VTE) and atrial fibrillation in this population is high. While direct data are lacking on the management of anticoagulation in dialysis patients, careful weighing of risks and benefits on the basis of evidence from...

    journal_title:Thrombosis research

    pub_type: 杂志文章,实务指引

    doi:10.1016/j.thromres.2005.03.031

    authors: Lo DS,Rabbat CG,Clase CM

    更新日期:2006-01-01 00:00:00

  • Expression of PAI-1, t-PA and u-PA in cultured human umbilical vein endothelial cells derived from racial groups.

    abstract::To determine whether inherent fibrinolytic differences may exist in racial groups (black americans, BA vs. white americans, WA), 55 different individual racially-derived human umbilical vein endothelial cell (HUVEC) cultures (35 BA and 20 WA) were analyzed in terms of their fibrinolytic protein (t-PA, u-PA and PAI-1) ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(95)91615-r

    authors: Frist ST,Taylor HA Jr,Kirk KA,Grammer JR,Li XN,Grenett HE,Booyse FM

    更新日期:1995-02-01 00:00:00

  • Inhibition of activated protein C by aprotinin and the use of the insolubilized inhibitor for its purification.

    abstract::The study of the interaction between activated protein C (APC) and non-plasmatic inhibitors allowed us to demonstrate that aprotinin is a potent competitive inhibitor of APC with a Ki of 1.35 mumol/L. It was possible to adsorb immunopurified protein C (PC) activated by venom activator to insolubilized aprotinin and to...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(90)90268-h

    authors: Taby O,Chabbat J,Steinbuch M

    更新日期:1990-07-01 00:00:00

  • Microsomal CA2+ uptake in human platelets is stimulated by calmodulin.

    abstract::Calcium accumulating vesicles were prepared from washed human platelets. Ca2+ uptake could be stimulated with calmodulin. The stimulation of Ca2+ uptake was not abolished by the adenylate cyclase inhibitor 2',5'-dideoxyadenosine, thus excluding enhanced cAMP formation as a possible cause for the calmodulin effect. Our...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(86)91697-x

    authors: Salimath BP,Mittelholzer E,Muggli R,Dieter P,Marmé D

    更新日期:1986-02-15 00:00:00

  • The molecular localization of the ability of certain monoclonal immunoglobulins to interfere with fibrin polymerization.

    abstract::When a purified myeloma protein with the ability to inhibit fibrin polymerization was preincubated with sheep anti-human F(ab')2 antibodies, there was a marked reduction of the ability to prolong the thrombin clotting time, while anti-Fc antibodies had only a slight effect. A monoclonal immunoglobulin which shortens t...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(85)90284-1

    authors: Wisløff F,Michaelsen TE,Kierulf P,Godal HC

    更新日期:1985-11-15 00:00:00

  • Interventional treatment of venous thromboembolism: a review.

    abstract::Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most common cardiovascular disease after coronary artery disease and cerebrovascular disease and is responsible for significant morbidity and mortality in the general population. Full dose anticoagulation is th...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/j.thromres.2011.11.003

    authors: Imberti D,Ageno W,Manfredini R,Fabbian F,Salmi R,Duce R,Gallerani M

    更新日期:2012-04-01 00:00:00

  • Treatment of haemophilia patients in East Germany prior to and after reunification in 1990.

    abstract::The reunification of Germany in 1990 brought with it major challenges in terms of unifying the care offered to haemophilia patients. At that time, most of the treatment centres belonged to the largest regional hospitals. The centre for paediatric haemophilia patients in Leipzig was at the University Hospital. In this ...

    journal_title:Thrombosis research

    pub_type: 历史文章,杂志文章,评审

    doi:10.1016/j.thromres.2013.10.018

    authors: Lenk H

    更新日期:2014-11-01 00:00:00

  • Plasminogen activator inhibitor-1 4G/5G genotype and residual venous occlusion following acute unprovoked deep vein thrombosis of the lower limb: A prospective cohort study.

    abstract:BACKGROUND:A recent study suggested that the plasminogen activator inhibitor (PAI)-1 4G/5G genotype may play a role in the resolution of deep vein thrombosis (DVT) after surgery. In the present study, we investigated the association between PAI-1 4G/5G genotype and the persistence of venous occlusion after acute idiopa...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2017.03.017

    authors: Giurgea GA,Brunner-Ziegler S,Jilma B,Sunder-Plassmann R,Koppensteiner R,Gremmel T

    更新日期:2017-05-01 00:00:00